Literature DB >> 7006575

Long-term drift and continued efficacy after multiyear timolol therapy.

R F Steinert, J V Thomas, W P Boger.   

Abstract

The clinical courses of 41 patients who received timolol maleate for experimental protocols were reviewed. We reevaluated the conditions of 17 patients with the elevated pressures of primary open angle glaucoma who had received timolol alone or in combination with other glaucoma medications for a maximum of 35 months (average, 26 months). Withdrawal of timolol led to an average intraocular pressure rise of 5 mm Hg. Eight patients treated with timolol alone showed a progressive, significant, 3-mm Hg upward rise, or "long-term drift" in IOP during the follow-up period. Pressure rise after timolol withdrawal, however, was not significantly less than pressure reduction when timolol was initiated. At least two weeks are required for "washout" or disappearance of timolol effect after timolol is withdrawn, and re-treatment for one week restores IOP to prewithdrawal levels.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7006575     DOI: 10.1001/archopht.1981.03930010102012

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  17 in total

Review 1.  Should beta blockers be abandoned as initial monotherapy in chronic open angle glaucoma? The controversy.

Authors:  I Goldberg
Journal:  Br J Ophthalmol       Date:  2002-06       Impact factor: 4.638

2.  Long-term assessment of prostaglandin analogs and timolol fixed combinations vs prostaglandin analogs monotherapy.

Authors:  Ai-Wei Liu; Lin-Yang Gan; Xiang Yao; Jian Zhou
Journal:  Int J Ophthalmol       Date:  2016-05-18       Impact factor: 1.779

Review 3.  Pharmacological therapy for glaucoma: a review.

Authors:  P F Hoyng; L M van Beek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

Review 4.  Topical dorzolamide 2%/timolol 0.5%: a review of its use in the treatment of open-angle glaucoma.

Authors:  D Ormrod; K McClellan
Journal:  Drugs Aging       Date:  2000-12       Impact factor: 3.923

5.  Long-term ocular hypotensive effect of levobunolol: results of a one-year study.

Authors:  M Ober; A Scharrer; R David; B Z Biedner; G D Novack; J C Lue; D S Robins; E Duzman
Journal:  Br J Ophthalmol       Date:  1985-08       Impact factor: 4.638

6.  Beta-blockers in the treatment of chronic simple glaucoma.

Authors:  R A Hitchings
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-10

7.  eNOS, a pressure-dependent regulator of intraocular pressure.

Authors:  W Daniel Stamer; Yuan Lei; Alexandra Boussommier-Calleja; Darryl R Overby; C Ross Ethier
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-12-09       Impact factor: 4.799

8.  The contralateral reduction of intraocular pressure by timolol.

Authors:  C N Dunham; R F Spaide; G Dunham
Journal:  Br J Ophthalmol       Date:  1994-01       Impact factor: 4.638

9.  Short-term and long-term timolol maleate effects on corneal sensitivity.

Authors:  D Spinelli; F Vigasio; P Montanari
Journal:  Doc Ophthalmol       Date:  1984-02-29       Impact factor: 2.379

Review 10.  Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects.

Authors:  A M Brooks; W E Gillies
Journal:  Drugs Aging       Date:  1992 May-Jun       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.